Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
RASSF6 encodes a member of the Ras-association domain family (RASSF). Zusätzlich bieten wir Ihnen RASSF6 Antikörper (59) und viele weitere Produktgruppen zu diesem Protein an.
Showing 3 out of 3 products:
Study reports the interaction of BCL-XL (zeige BCL2L1 Proteine) with RASSF6. BCL-XL (zeige BCL2L1 Proteine) inhibits the interaction between RASSF6 and MDM2 (zeige MDM2 Proteine) and suppresses p53 (zeige TP53 Proteine) expression. Consequently, BCL-XL (zeige BCL2L1 Proteine) antagonizes RASSF6-mediated apoptosis. Thus, the inhibition of RASSF6-mediated apoptosis also underlies the prosurvival role of BCL-XL (zeige BCL2L1 Proteine).
Data suggest that Ras-association domain family protein 6 (RASSF6) may serve as a candidate against tumor growth for sporadic colorectal cancer (sCRC).
RASSF6 and RASSF10 were frequently hypermethylated in the samples at the time of diagnosis of adult acute lymphoblastic leukemia patients
Overexpression or silencing of RASSF6 could partially reverse the effects of the overexpression or repression of miR (zeige MLXIP Proteine)-181a-5p on GC progress caused by activation of the MAKP pathway in vitro and in vivo.
Results suggest that down-regulation of RASSF2 (zeige RASSF2 Proteine), and RASSF6 is a tumor-specific phenomenon and their inactivation through CpG island methylation may play important roles in gastric cardia carcinogenesis.
Mechanistic investigation shows that RASSF6 triggers p21(Cip1/Waf1 (zeige CDKN1A Proteine)) accumulation to induce G 1 cell cycle arrest and promote apoptosis upon exposure to pro-apoptotic agents, and both of these mechanisms appear to be mediated by activated JNK (zeige MAPK8 Proteine) signaling.
RASSF6 expression is an independent biomarker of an unfavorable prognosis in patients with pancreatic ductal adenocarcinoma.
RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells.RASSF6 exhibits the highest frequency of inactivation in melanoma and in melanoma brain metastases.
downregulation of RASSF6 in highly metastatic nasopharyngeal carcinoma cells contributed to their treatment resistance
RASSF6-induced apoptosis partially depends on p53 (zeige TP53 Proteine). RASSF6 binds MDM2 (zeige MDM2 Proteine) and facilitates its ubiquitination. RASSF6 depletion blocks the increase of p53 (zeige TP53 Proteine) in response to UV exposure and up-regulation of p53 (zeige TP53 Proteine) target genes.
RASSF6 expression in adipocytes is down-regulated by interaction with macrophages.
Demonstrates properties of a Ras effector and tumor suppressor but exhibits biological properties that are unique and distinct from those of other family members.
This gene encodes a member of the Ras-association domain family (RASSF). Members of this family form the core of a highly conserved tumor suppressor network, the Salvador-Warts-Hippo (SWH) pathway. The protein encoded by this gene is a Ras effector protein that induces apoptosis. A genomic region containing this gene has been linked to susceptibility to viral bronchiolitis. Alternative splicing results in multiple transcript variants and protein isoforms.
Ras association (RalGDS/AF-6) domain family 6
, putative RAS binding protein
, ras association domain-containing protein 6